Literature DB >> 34311326

SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.

Huarong Chen1, Weixin Liu2, Yifei Wang3, Dabin Liu2, Liuyang Zhao2, Jun Yu2.   

Abstract

BACKGROUND: The outbreak of Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 infection has become a global health emergency. We aim to decipher SARS-CoV-2 infected cell types, the consequent host immune response and their interplay in lung of COVID-19 patients.
METHODS: We analyzed single-cell RNA sequencing (scRNA-seq) data of bronchoalveolar lavage fluid (BALF) samples from 10 healthy donors, 6 severe COVID-19 patients and 3 mild recovered patients. The expressions of SARS-CoV-2 receptors (ACE2 and TMPRSS2) were examined among different cell types. The immune cells infiltration patterns, their expression profiles, and interplays between immune cells and SARS-CoV-2 target cells were further investigated.
FINDINGS: Compared to healthy controls, ACE2 and TMPRSS2 expressions were significantly higher in lung epithelial cells of COVID-19 patients, in particular club and ciliated cells. SARS-CoV-2 activated pro-inflammatory genes and interferon/cytokine signaling in these cells. In severe COVID-19 patients, significantly higher neutrophil, but lower macrophage in lung was observed along with markedly increased cytokines expression compared with healthy controls and mild patients. By contrast, neutrophil and macrophage returned to normal level whilst more T and NK cells accumulation were observed in mild patients. Moreover, SARS-CoV-2 infection altered the community interplays of lung epithelial and immune cells: interactions between the club and immune cells were higher in COVID-19 patients compared to healthy donors; on the other hand, immune-immune cells interactions appeared the strongest in mild patients.
INTERPRETATION: SARS-CoV-2 could infect lung epithelium, alter communication patterns between lung epithelial cells and immune system, and drive dysregulated host immune response in COVID-19 patients.
Copyright © 2021 The Author(s). Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  COVID-19; Dysregulated immune response; SARS-CoV-2; lung epithelium; scRNA-seq

Year:  2021        PMID: 34311326     DOI: 10.1016/j.ebiom.2021.103500

Source DB:  PubMed          Journal:  EBioMedicine        ISSN: 2352-3964            Impact factor:   8.143


  14 in total

Review 1.  Pathogenic Mechanism and Multi-omics Analysis of Oral Manifestations in COVID-19.

Authors:  Ming Hao; Dongxu Wang; Qianyun Xia; Shaoning Kan; Lu Chang; Huimin Liu; Zhijing Yang; Weiwei Liu
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 2.  Exploring the Utility of NK Cells in COVID-19.

Authors:  Xuewen Deng; Hiroshi Terunuma; Mie Nieda
Journal:  Biomedicines       Date:  2022-04-26

Review 3.  The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy.

Authors:  Yiran Wang; Mandi Wu; Yichen Li; Ho Him Yuen; Ming-Liang He
Journal:  J Biomed Sci       Date:  2022-05-03       Impact factor: 12.771

4.  Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.

Authors:  Aliakbar Hasankhani; Abolfazl Bahrami; Negin Sheybani; Behzad Aria; Behzad Hemati; Farhang Fatehi; Hamid Ghaem Maghami Farahani; Ghazaleh Javanmard; Mahsa Rezaee; John P Kastelic; Herman W Barkema
Journal:  Front Immunol       Date:  2021-12-15       Impact factor: 7.561

5.  Immunological Characterization of HIV and SARS-CoV-2 Coinfected Young Individuals.

Authors:  Claudia Vanetti; Daria Trabattoni; Marta Stracuzzi; Antonella Amendola; Clara Fappani; Valeria Rubinacci; Claudio Fenizia; Laura Gianolio; Mara Biasin; Anna Dighera; Irma Saulle; Elisabetta Tanzi; Gianvincenzo Zuccotti; Mario Clerici; Vania Giacomet
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

6.  Achromobacter xylosoxidans Purulent Bronchitis in a Previously Healthy Child: An Unexpected Consequence of COVID-19 Infection.

Authors:  Nusa Matijasic; Ana Tripalo Batos; Jasna Lenicek Krleza; Marijana Rogulj; Ivan Pavic
Journal:  Cureus       Date:  2022-01-29

Review 7.  COVID-19 and the Vasculature: Current Aspects and Long-Term Consequences.

Authors:  Berenice Martínez-Salazar; Melle Holwerda; Chiara Stüdle; Indre Piragyte; Nadia Mercader; Britta Engelhardt; Robert Rieben; Yvonne Döring
Journal:  Front Cell Dev Biol       Date:  2022-02-15

8.  mRNA expression of toll-like receptors 3, 7, 8, and 9 in the nasopharyngeal epithelial cells of coronavirus disease 2019 patients.

Authors:  Zahra Bagheri-Hosseinabadi; Ebrahim Rezazadeh Zarandi; Mohammad Mirabzadeh; Ali Amiri; Mitra Abbasifard
Journal:  BMC Infect Dis       Date:  2022-05-10       Impact factor: 3.667

9.  Co-Regulation of Protein Coding Genes by Transcription Factor and Long Non-Coding RNA in SARS-CoV-2 Infected Cells: An In Silico Analysis.

Authors:  Chinmay Saha; Sayantan Laha; Raghunath Chatterjee; Nitai P Bhattacharyya
Journal:  Noncoding RNA       Date:  2021-11-29

Review 10.  COVID-19 infection, progression, and vaccination: Focus on obesity and related metabolic disturbances.

Authors:  Annemarie J F Westheim; Albert V Bitorina; Jan Theys; Ronit Shiri-Sverdlov
Journal:  Obes Rev       Date:  2021-07-16       Impact factor: 10.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.